Meanwhile, it has been shown that mangiferin’s anti-inflammatory effects are mediated by blocking the NLRP3-inflammasome/caspase-1/IL-1β pathway, which is believed to have a role in the development of depression. This evidence concerns the gene IL1B and major depressive disorder.